A hotly debated lung cancer drug cut the risk of death by 34% in a late-stage trial in China - CNBC
Source:CNBC
An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a late-stage trial, according to data released Sunday.
Related Articles
Aurora’s driverless trucks can now travel farther distances faster than human drivers - TechCrunch
CEO Chris Urmson called it a “superhuman” moment, adding that Aurora’s trucks can now carry freight …
'Sell America' has sparked a FOMO-fueled rush to gold and silver among everyday investors - Business Insider
Precious metals markets saw record inflows in 2025, with investors reacting to US economic …
United Tries to Offset Temporary High Fuel Costs With Permanent Fare and Fee Increases - Cranky Flier
None
Teens allege Musk’s Grok chatbot made sexual images of them as minors - The Washington Post
Three teenage plaintiffs in a lawsuit filed Monday accuse xAI of distributing, possessing and …